Literature DB >> 22466646

MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice.

Magali Noval Rivas1, Yi T Koh, Andrew Chen, Annie Nguyen, Young Ho Lee, Greg Lawson, Talal A Chatila.   

Abstract

Tregs expressing the transcription factor Foxp3 suppress self-reactive T cells, prevent autoimmunity, and help contain immune responses to foreign antigens, thereby limiting the potential for inadvertent tissue damage. Mutations in the FOXP3 gene result in Treg deficiency in mice and humans, which leads to the development of a multisystem autoimmune inflammatory disease. The contribution of dysregulated innate immune responses to the pathogenesis of Foxp3 deficiency disease is unknown. In this study, we examined the role of microbial signals in the pathogenesis of Foxp3 deficiency disease by studying Foxp3 mutant mice that had concurrent deficiencies in TLR signaling pathways. Global deficiency of the common TLR adaptor MyD88 offered partial protection from Foxp3 deficiency disease. Specifically, it protected from disease at the environmental interfaces of the skin, lungs, and gut. In contrast, systemic disease, in the form of unrestrained lymphoproliferation, continued unabated. The effect of MyD88 deficiency at environmental interfaces involved the disruption of chemokine gradients that recruit effector T cells and DCs, resulting in their entrapment in secondary lymphoid tissues. These results suggests that Tregs have a key role in maintaining tolerance at host-microbial interfaces by restraining tonic MyD88-dependent proinflammatory signals. Moreover, microbial factors may play a substantial role in the pathogenesis of human autoimmune disease resulting from Treg deficiency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466646      PMCID: PMC3336968          DOI: 10.1172/JCI40591

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Regulatory T cell development in the absence of functional Foxp3.

Authors:  Wen Lin; Dipica Haribhai; Lance M Relland; Nga Truong; Marc R Carlson; Calvin B Williams; Talal A Chatila
Journal:  Nat Immunol       Date:  2007-02-02       Impact factor: 25.606

3.  Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling.

Authors:  Nicholas S Wilson; Louise J Young; Fiona Kupresanin; Shalin H Naik; David Vremec; William R Heath; Shizuo Akira; Ken Shortman; Jeff Boyle; Eugene Maraskovsky; Gabrielle T Belz; José A Villadangos
Journal:  Immunol Cell Biol       Date:  2007-11-20       Impact factor: 5.126

4.  The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

5.  Keratinocyte expression of intercellular adhesion molecule 1 (ICAM-1) correlated with infiltration of lymphocyte function associated antigen 1 (LFA-1) positive cells in evolving allergic contact dermatitis reactions.

Authors:  J J Garioch; R M Mackie; I Campbell; A Forsyth
Journal:  Histopathology       Date:  1991-10       Impact factor: 5.087

6.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

Review 7.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

8.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

9.  Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice.

Authors:  Fabrina Gaspal; David Withers; Manoj Saini; Vasileios Bekiaris; Fiona M McConnell; Andrea White; Mahmood Khan; Hideo Yagita; Lucy S K Walker; Graham Anderson; Peter J L Lane
Journal:  J Exp Med       Date:  2011-07-25       Impact factor: 14.307

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  27 in total

Review 1.  The Microbiome, Systemic Immune Function, and Allotransplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

Review 2.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

3.  Itch expression by Treg cells controls Th2 inflammatory responses.

Authors:  Hyung-seung Jin; Yoon Park; Chris Elly; Yun-Cai Liu
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

4.  Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice.

Authors:  J J Wang; G-X Yang; W C Zhang; L Lu; K Tsuneyama; M Kronenberg; J L Véla; M Lopez-Hoyos; X-S He; W M Ridgway; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 5.  Microbiota—implications for immunity and transplantation.

Authors:  Jonathan S Bromberg; W Florian Fricke; C Colin Brinkman; Thomas Simon; Emmanuel F Mongodin
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

6.  T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis.

Authors:  Christophe Cataisson; Rosalba Salcedo; Aleksandra M Michalowski; Mary Klosterman; Shruti Naik; Luowei Li; Michelle J Pan; Amalia Sweet; Jin-Qiu Chen; Laurie G Kostecka; Megan Karwan; Loretta Smith; Ren-Ming Dai; C Andrew Stewart; Lyudmila Lyakh; Wang-Ting Hsieh; Asra Khan; Howard Yang; Maxwell Lee; Giorgio Trinchieri; Stuart H Yuspa
Journal:  Mol Cancer Res       Date:  2019-06-04       Impact factor: 5.852

7.  Irgm1 coordinately regulates autoimmunity and host defense at select mucosal surfaces.

Authors:  Kathleen M Azzam; Jennifer H Madenspacher; Derek W Cain; Lihua Lai; Kymberly M Gowdy; Prashant Rai; Kyathanahalli Janardhan; Natasha Clayton; Willie Cunningham; Heather Jensen; Preeyam S Patel; John F Kearney; Gregory A Taylor; Michael B Fessler
Journal:  JCI Insight       Date:  2017-08-17

8.  Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  S Xing; X Zhang; J H Liu; X Huang; P Zhou
Journal:  Clin Exp Immunol       Date:  2018-10-14       Impact factor: 4.330

Review 9.  T cells and intestinal commensal bacteria--ignorance, rejection, and acceptance.

Authors:  Jiani N Chai; You W Zhou; Chyi-Song Hsieh
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

Review 10.  Genetic dissection of dendritic cell homeostasis and function: lessons from cell type-specific gene ablation.

Authors:  Peer W F Karmaus; Hongbo Chi
Journal:  Cell Mol Life Sci       Date:  2013-12-24       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.